SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Arena Pharmaceuticals, Inc. (ARNA)

Looking great today!!! Maybe there will be no

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Globaltrnr Member Profile
 
Followed By 65
Posts 7,326
Boards Moderated 0
Alias Born 10/12/09
160x600 placeholder
Arena Pharmaceuticals Completes Full Enrollment in Etrasimod Phase 2 Clinical Study for Ulcerative Colitis "PR Newswire (US)" - 11/10/2017 11:31:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/8/2017 4:15:29 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/7/2017 4:05:26 PM
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2017 Financial Results "PR Newswire (US)" - 11/7/2017 4:01:00 PM
Arena Pharmaceuticals to Present at the Credit Suisse Healthcare Conference on November 8 "PR Newswire (US)" - 10/31/2017 8:30:00 AM
Arena Pharmaceuticals to Release Third Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, November 7 "PR Newswire (US)" - 10/30/2017 8:30:00 AM
Standout Players Find Varied, Innovative Means of Serving the Marijuana Industry "NetworkNewsWire" - 10/19/2017 8:45:00 AM
Arena Pharmaceuticals Announces Late Breaking Presentation of Positive Phase 2 Results with Ralinepag in Patients with Pulmon... "PR Newswire (US)" - 10/19/2017 8:30:00 AM
Arena Pharmaceuticals to Present Additional Pre-Clinical Data on Ralinepag for Treatment of Pulmonary Arterial Hypertension a... "PR Newswire (US)" - 9/6/2017 8:30:00 AM
Arena Pharmaceuticals to Present Additional Pre-Clinical Data on Ralinepag for Treatment of Pulmonary Arterial Hypertension a... "PR Newswire (US)" - 8/22/2017 8:30:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/8/2017 4:11:18 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2017 4:04:54 PM
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2017 Financial Results "PR Newswire (US)" - 8/7/2017 4:01:00 PM
Arena Pharmaceuticals to Release Second Quarter 2017 Financial Results and Provide Corporate Update on Monday, August 7, 2017 "PR Newswire (US)" - 7/31/2017 4:32:00 PM
Arena Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares "PR Newswire (US)" - 7/31/2017 8:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/13/2017 4:11:32 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 7/13/2017 4:08:29 PM
Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock "PR Newswire (US)" - 7/12/2017 8:11:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/11/2017 5:18:39 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 7/11/2017 4:40:35 PM
Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock "PR Newswire (US)" - 7/11/2017 4:05:00 PM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) "Edgar (US Regulatory)" - 7/11/2017 4:03:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/10/2017 4:25:41 PM
Arena Pharmaceuticals Reports Positive Topline Phase 2 Results for Ralinepag in Patients with Pulmonary Arterial Hypertension "PR Newswire (US)" - 7/10/2017 4:01:00 PM
Arena Pharmaceuticals Completes Trial Comparing Once-Daily, Extended Release Formulation of Ralinepag with Twice-Daily, Immed... "PR Newswire (US)" - 6/29/2017 8:30:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist